Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation

Publisher Website
Google Scholar
Abstract
The analgesic effect and adverse events of the weak opioid codeine is assumed to be mediated by its metabolite morphine. The cytochrome P-450 enzyme CYP2D6 catalysing the formation of morphine exhibits a genetic polymorphism. Two distinct phenotypes, the extensive (EMs) and poor metabolisers